The Tough Tech problem we are solving
Microbe-based products are an inevitable future in medicine, food, and consumer goods. The major challenge in creating these products—and capturing their economic potential—is intelligence: accurately predicting the right microbes to ensure a product’s optimal effectiveness. Concerto uniquely owns extensive datasets, generated by our proprietary coculture screening device, that fuel accurate AI-powered predictions, positioning us as the leader in unlocking this new scientific and economic frontier.
About our solution
Concerto measures, maps, and harnesses the microbial world to create best-in-class therapies and products that achieve real-world efficacy through naturally occurring symbioses among microbes. Powering discovery is our intelligence platform: kChip generates vast datasets (40M+ combinations constructed and measured) to train kAI, our generalized model of microbial ecology. We're advancing a pipeline across dermatology (ENS-002 live biotherapeutic for eczema now in clinic, countering S. aureus), women's health, food science (CB-002 postbiotic ferment), and beyond, transforming microbial ecosystems into sustainable solutions for health and planet.